Clinical Trial Update: ProAir Digihaler in COPD Disease Management: A Real World Study

View source ↗

Summary

Real-world study results for ProAir Digihaler in COPD disease management are reported; the trial (NCT04821869) is completed and results were posted on 2025-06-1…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Exacerbation of Chronic Obstructive Pulmonary Disease

Drugs mentioned

• ProAir Digihaler (albuterol sulfate)

Snippet

Sponsor: Pulmonary Research Institute of Southeast Michigan | Conditions: COPD, COPD Exacerbation Acute | Status: COMPLETED | Results posted: 2025-06-13